Mycobacterium marinum: An Increasingly Common Opportunistic Infection in Patients on Infliximab

Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
The American Journal of Gastroenterology (Impact Factor: 10.76). 08/2012; 107(8):1268-9. DOI: 10.1038/ajg.2012.118
Source: PubMed


The American Journal of Gastroenterology is published by Nature Publishing Group (NPG) on behalf of the American College of Gastroenterology (ACG). Ranked the #1 clinical journal covering gastroenterology and hepatology*, The American Journal of Gastroenterology (AJG) provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients. Published with practicing clinicians in mind, the journal aims to be easily accessible, organizing its content by topic, both online and in print., *2007 Journal Citation Report (Thomson Reuters, 2008)

1 Follower
11 Reads
  • Source
    • "These infections can become severe, requiring prolonged multi-antibiotic therapy and/or surgical interventions (Bonamonte et al., 2013; Huang et al., 2012; Wu et al., 2012). In patients being treated with immunosuppressive drugs, these infections can be more prevalent and severe (Ferreira et al., 2012). Superficial infection can rarely disseminate to bones and joints or cause a pulmonary infection (Bonamonte et al., 2013; Wu et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aquatic habitats harbor a multitude of bacterial species. Many of these bacteria can act as pathogens to aquatic species and/or non-aquatic organisms, including humans, that come into contact with contaminated water sources or colonized aquatic organisms. In many instances, the bacteria are not pathogenic to the aquatic species they colonize and are only considered pathogens when they come into contact with humans. There is a general lack of knowledge about how the environmental lifestyle of these pathogens allows them to persist, replicate and produce the necessary pathogenic mechanisms to successfully transmit to the human host and cause disease. Recently, the zebrafish infectious disease model has emerged as an ideal system for examining aquatic pathogens, both in the aquatic environment and during infection of the human host. This review will focus on how the zebrafish has been used successfully to analyze the pathogenesis of aquatic bacterial pathogens.
    Full-text · Article · Mar 2014 · Developmental and comparative immunology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nontuberculous mycobacterioses comprise a group of diseases caused by mycobacteria which do not belong to the Mycobacterium (M.) tuberculosis complex and are not ascribed to M. leprae. These mycobacteria are characterized by a broad variety as to environmental distribution and adaptation. Some of the species may cause specific diseases, especially in patients with underlying immunosuppressive diseases, chronic pulmonary diseases or genetic predisposition, respectively. Worldwide a rising prevalence and significance of nontuberculous mycobacterioses can be recognized. The present recommendations summarise actual aspects of epidemiology, pathogenesis, clinical aspects, diagnostics - especially microbiological methods including susceptibility testing -, and specific treatment for the most relevant species. Diagnosis and treatment of nontuberculous mycobacterioses during childhood and in HIV-infected individuals are described in separate chapters.
    No preview · Article · Nov 2013 · Pneumologie
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tumor necrosis factor-alfa levels are linked to disease severity in patients with inflammatory conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant success in the treatment of such inflammatory disorders. Their use, however, can be plagued by infectious complications. An awareness of potential infections associated with these therapies is critical in order to maximize preventive efforts both before and during therapy. This review provides a guide for dermatologists caring for patients in need of this type of biologic therapy to preemptively address the infectious risks. Part I of this continuing medical education article reviews background information on the various infectious risks associated with tumor necrosis factor inhibitor therapy and appropriate historical data to obtain in the context of pretherapy evaluations.
    No preview · Article · Jul 2014 · Journal of the American Academy of Dermatology
Show more